Ubs Group Ag INHIBIKASE THERAPEUTICS INC Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
Number of Shares
27,526
Previous 4,873
464.87%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%